RECENT UPDATE ON PYRIMIDINE DERIVATIVES AS POTENTIAL DPP-IV INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS. Journal of Pharmaceutical Negative Results [Internet]. 2022 Dec. 28 [cited 2026 Jun. 11];:5734-43. Available from: https://www.pnrjournal.com/index.php/home/article/view/5581